Pimecrolimus - PDFSEARCH.IO - Document Search Engine

Pimecrolimus
Results: 56

#	Item
31	DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD[removed]DATE: Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-02-11 16:14:03 Oncology Lymphoma Type 1 hypersensitivity Pimecrolimus Tacrolimus Calcineurin Atopy Atopic dermatitis Adverse Event Reporting System Medicine Immunosuppressants Macrolides
32	MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-02-11 16:14:02 Medicine Pharmaceutical sciences Tacrolimus Pimecrolimus Food and Drug Administration Drug development Adverse effect Off-label use Pharmacology Immunosuppressants Macrolides
33	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Date: Add to Reading List Source URL: www.fda.gov Language: English Macrolides Type 1 hypersensitivity Microbiology Tacrolimus Pimecrolimus Atopic dermatitis Eczema Adverse Event Reporting System Atopy Bacteria Immunosuppressants Medicine
34	Topical Calcineurin Inhibitors Pediatric Safety Update: Regulatory Background Amy Sakulich Woitach, D.O., M.S. Medical Officer Division of Dermatology and Dental Products Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Health Medicine Tacrolimus Pimecrolimus Atopic dermatitis Boxed warning Atopy Calcineurin Immunosuppressants Macrolides Type 1 hypersensitivity
35	CO-1 ELIDEL® (pimecrolimus) Cream 1% FDA Pediatric Advisory Committee Meeting March 22, 2010 Add to Reading List Source URL: www.fda.gov Language: English Pimecrolimus Tacrolimus Health Medicine Autoimmune diseases Atopic dermatitis Eczema Atopy Dermatitis Immunosuppressants Macrolides Type 1 hypersensitivity
36	Microsoft PowerPoint - Protopic PAC final[removed]11pm.pptx Add to Reading List Source URL: www.fda.gov Language: English Macrolides Health Type 1 hypersensitivity Tacrolimus Mycosis fungoides Cutaneous T-cell lymphoma Eczema Pimecrolimus Atopic dermatitis Lymphoma Medicine Immunosuppressants
37	Topical pimecrolimus (Elidel) and tacrolimus (Protopic)Update of Safety Profile Lois La Grenade, MD , MPH FDA / CDER / OSE / DPV I Pediatric Advisory Committee March 22, 2010 Add to Reading List Source URL: www.fda.gov Language: English Pimecrolimus Tacrolimus Adverse Event Reporting System Calcineurin Blastoma Cancer The Truth About Cars Lymphoma Medicine Immunosuppressants Macrolides
38	Topical Calcineurin Inhibitors Pediatric Safety Update: Regulatory Background Amy Sakulich Woitach, D.O., M.S. Medical Officer Division of Dermatology and Dental Products Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Tacrolimus Health Medicine Pimecrolimus Atopic dermatitis Boxed warning Atopy Calcineurin Immunosuppressants Macrolides Type 1 hypersensitivity
39	Microsoft PowerPoint - Novartis Elidel PAC[removed]ppt Add to Reading List Source URL: www.fda.gov Language: English Pimecrolimus Health Tacrolimus Medicine Eczema Atopic dermatitis Atopy Itch Melanoma Immunosuppressants Macrolides Type 1 hypersensitivity
40	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Add to Reading List Source URL: www.fda.gov Language: English Medicine Chemistry Tacrolimus Pimecrolimus Pharmacology Atopic dermatitis Atopy Medical prescription Astellas Pharma Immunosuppressants Macrolides Type 1 hypersensitivity